Ipilimumab Injection

Generic name: Pronounced as (ip'' i lim' ue mab)
Brand names
  • Yervoy®
Click on drug name to hear pronunciation

Medical Content Reviewed By HelloPharmacist Staff

Last Revised - 10/15/2021

Ipilimumab injection is used:

  • to treat melanoma (a type of skin cancer) in adults and children 12 years of age and older that cannot be treated with surgery or that has spread to other parts of the body. It is also used in combination with nivolumab (Opdivo) to treat melanoma in adults that cannot be treated with surgery or that has spread to other parts of the body.

  • to treat and prevent the return of a certain type of melanoma after surgery to remove it and any affected lymph nodes.

  • in combination with nivolumab to treat advanced renal cell carcinoma (RCC; a type of cancer that begins in the cells of the kidneys).

  • in combination with nivolumab to treat certain types of colorectal cancer (cancer that begins in the large intestine) in adults and children 12 years of age and older that has spread to other parts of the body and has worsened after treatment with other chemotherapy medications.

  • in combination with nivolumab to treat hepatocellular carcinoma (HCC; a type of liver cancer) in people who were previously treated with sorafenib (Nexafar).

  • in combination with nivolumab to a certain type of lung cancer (non-small cell lung cancer; NSCLC) in adults that has spread to other parts of the body.

  • in combination with nivolumab and platinum chemotherapy to treat a certain type of NSCLC in adults that has returned or has spread to other parts of the body.

  • in combination with nivolumab to treat malignant pleural mesothelioma (a type of cancer that affects the inside lining of the lungs and chest cavity) in adults that cannot be removed by surgery.

Ipilimumab injection is in a class of medications called monoclonal antibodies. It works by helping the body to slow or stop the growth of cancer cells.

Ipilimumab injection comes as a solution (liquid) to be injected intravenously (into a vein) by a doctor or nurse in a hospital or medical facility. When ipilimumab is given alone to treat and help prevent the return of melanoma, it is usually given over 90 minutes once every 3 weeks for 4 doses and then once every 12 weeks as long as your doctor recommends that you receive treatment. When ipilimumab is given alone or along with nivolumab to treat melanoma, it is usually given over 90 minutes once every 3 weeks for up to 4 doses. When ipilimumab is given with nivolumab to treat renal cell carcinoma, hepatocellular carcinoma, or colorectal cancer, it is usually given over 30 minutes once every 3 weeks for up to 4 doses. When ipilimumab is given with nivolumab or with nivolumab and platinum chemotherapy to treat NSCLC, it is usually given over 30 minutes once every 6 weeks for as long as your doctor recommends that you receive treatment. When ipilimumab is given with nivolumab to treat malignant pleural mesothelioma, it is usually given over 30 minutes once every 6 weeks for as long as your doctor recommends that you receive treatment.

Ipilimumab injection may cause serious or life-threatening reactions during an infusion. A doctor or nurse will watch you closely while you are receiving the infusion and shortly after the infusion to be sure you are not having a serious reaction to the medication. Tell your doctor or nurse immediately if you experience any of the following symptoms that may occur during the infusion: chills or shaking, itching, rash, flushing, difficulty breathing, dizziness, fever, or feeling faint.

Your doctor may slow down your infusion, delay, or stop your treatment with ipilimumab injection, or treat you with additional medications depending on your response to the medication and any side effects that you experience. Talk to your doctor about how you are feeling during your treatment.

Your doctor or pharmacist will give you the manufacturer's patient information sheet (Medication Guide) when you begin treatment with ipilimumab and each time you refill your prescription. Read the information carefully and ask your doctor or pharmacist if you have any questions. You can also visit the Food and Drug Administration (FDA) website (http://www.fda.gov/Drugs/DrugSafety/ucm085729.htm) or the manufacturer's website to obtain the Medication Guide.

This medication may be prescribed for other uses; ask your doctor or pharmacist for more information.

Before receiving ipilimumab injection,

  • tell your doctor and pharmacist if you are allergic to ipilimumab injection, any other medications, or any of the ingredients in ipilimumab injection. Ask your pharmacist or check the Medication Guide for a list of the ingredients.

  • tell your doctor and pharmacist what prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products you are taking or plan to take. Your doctor may need to change the doses of your medications or monitor you carefully for side effects.

  • tell your doctor if you have received or plan to receive a stem cell transplant that uses donor stem cells (allogeneic) or have ever had an organ transplant. Also, tell your doctor if you have or have ever had an autoimmune disease (condition in which the immune system attacks a healthy part of the body) such as Crohn's disease (condition in which the immune system attacks the lining of the digestive tract causing pain, diarrhea, weight loss, and fever), ulcerative colitis (a condition which causes swelling and sores in the lining of the colon [large intestine] and rectum), lupus (a condition in which the immune system attacks many tissues and organs including the skin, joints, blood, and kidneys); any condition that affects your nervous system such as myasthenia gravis (a disorder of the nervous system that causes muscle weakness) or Guillain-Barré syndrome (weakness, tingling, and possible paralysis due to sudden nerve damage); thyroid problems; or liver disease.

  • tell your doctor if you are pregnant or plan to become pregnant. You will need to take a pregnancy test before you receive ipilimumab. You should use effective birth control to prevent pregnancy during your treatment with ipilimumab injection and for 3 months after your final dose. Talk to your doctor about birth control methods that will work for you. If you become pregnant while receiving ipilimumab injection, call your doctor immediately. Ipilimumab injection may harm the fetus.

  • tell your doctor if you are breastfeeding or plan to breastfeed. You should not breastfeed while receiving ipilimumab injection and for 3 months after your final dose.

Unless your doctor tells you otherwise, continue your normal diet.

  • Ipilimumab may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:

    • difficulty falling asleep or staying asleep

    • joint pain

  • Some side effects can be serious. If you experience any of the symptoms, call your doctor immediately or get emergency medical treatment.

    • decreased urination, blood in urine, swelling of feet, ankles, or lower legs, or loss of appetite

    • diarrhea, bloody or black, tarry, sticky stools, severe stomach pain or tenderness, or fever

    • cough, chest pain, or shortness of breath

    • tiredness, confusion, memory problems, hallucinations, seizures, or stiff neck

    • feeling tired, increased appetite, increased thirst, increased urination, or weight loss

    • rapid heartbeat, uncontrollable shaking of a part of the body or sweating

    • fatigue or sluggishness, increased sensitivity to cold, constipation, muscle ache and weakness, weight gain, heavier than normal or irregular menstrual periods, thinning hair, headache, dizziness, irritability, forgetfulness, decreased sex drive, or depression

    • yellowing of skin or eyes, dark (tea-colored) urine, pain in upper right part of the stomach, nausea, vomiting, or easy bruising or bleeding

    • unusual weakness of legs, arms, or face; or numbness or tingling in hands or feet

    • rash with or without itching, blistering or peeling skin, or mouth sores

    • blurred vision, double vision, eye pain or redness, or other vision problems

  • Ipilimumab injection may cause other side effects. Call your doctor if you have any unusual problems while you are receiving this medication.

  • If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online (http://www.fda.gov/Safety/MedWatch) or by phone (1-800-332-1088).

In case of overdose, call the poison control helpline at 1-800-222-1222. Information is also available online at https://www.poisonhelp.org/help. If the victim has collapsed, had a seizure, has trouble breathing, or can't be awakened, immediately call emergency services at 911.

Ask your pharmacist any questions you have about ipilimumab injection.

Keep all appointments with your doctor and the laboratory. Your doctor will order certain tests before and during your treatment to see if it is safe for you to receive ipilimumab injection and to check your body's response to ipilimumab injection.

For some conditions, your doctor will order a lab test before you begin your treatment to see whether your cancer can be treated with ipilimumab.

Ask your pharmacist any questions you have about ipilimumab injection.

It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.

Drug Interaction
Cilostazol Cilostazol Cilostazol may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Estrogen and Progestin (Oral Contraceptives) Estrogen and Progestin (Oral Contraceptives) Conjugated estrogens may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Fenofibrate Fenofibrate Fenofibrate may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Guanfacine Guanfacine Guanfacine may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Magnesium Hydroxide Magnesium Hydroxide Ipilimumab may decrease the excretion rate of Magnesium hydroxide which could result in a higher serum level.
Mycophenolate Mycophenolate Mycophenolic acid may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Olsalazine Olsalazine Olsalazine may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Potassium Potassium Potassium cation may increase the excretion rate of Ipilimumab which could result in a lower serum level and potentially a reduction in efficacy.
Prednisone Prednisone Prednisone may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Ranitidine Ranitidine Ranitidine may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Reserpine Reserpine Reserpine may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Rizatriptan Rizatriptan Rizatriptan may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Sumatriptan Sumatriptan Sumatriptan may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Tacrolimus Tacrolimus Tacrolimus may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Ampicillin Injection Ampicillin Injection Ampicillin may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Doxycycline Injection Doxycycline Injection Doxycycline may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Fluconazole Injection Fluconazole Injection Fluconazole may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Foscarnet Injection Foscarnet Injection Foscarnet may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Hydromorphone Injection Hydromorphone Injection Hydromorphone may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Levofloxacin Injection Levofloxacin Injection Levofloxacin may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Meperidine Injection Meperidine Injection Meperidine may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Metoclopramide Injection Metoclopramide Injection Metoclopramide may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Pamidronate Injection Pamidronate Injection Pamidronic acid may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Vancomycin Injection Vancomycin Injection Ipilimumab may decrease the excretion rate of Vancomycin which could result in a higher serum level.
Altretamine Altretamine Amphetamine may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Cefuroxime Cefuroxime Cefuroxime may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Cyclosporine Cyclosporine Cyclosporine may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Torsemide Torsemide Torasemide may increase the excretion rate of Ipilimumab which could result in a lower serum level and potentially a reduction in efficacy.
Meloxicam Meloxicam Meloxicam may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Pantoprazole Pantoprazole Pantoprazole may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Temozolomide Temozolomide Temozolomide may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Zaleplon Zaleplon Zaleplon may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Perindopril Perindopril Perindopril may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Tenofovir Tenofovir Tenofovir may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Choline Magnesium Trisalicylate Choline Magnesium Trisalicylate Choline magnesium trisalicylate may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Eplerenone Eplerenone Eplerenone may increase the excretion rate of Ipilimumab which could result in a lower serum level and potentially a reduction in efficacy.
Zonisamide Zonisamide Zonisamide may increase the excretion rate of Ipilimumab which could result in a lower serum level and potentially a reduction in efficacy.
Adalimumab Injection Adalimumab Injection The risk or severity of adverse effects can be increased when Adalimumab is combined with Ipilimumab.
Atomoxetine Atomoxetine Atomoxetine may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Atazanavir Atazanavir Atazanavir may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Almotriptan Almotriptan Almotriptan may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Omalizumab Injection Omalizumab Injection The risk or severity of adverse effects can be increased when Omalizumab is combined with Ipilimumab.
Emtricitabine Emtricitabine Emtricitabine may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Memantine Memantine Memantine may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Tadalafil Tadalafil Tadalafil may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Darbepoetin Alfa Injection Darbepoetin Alfa Injection The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Ipilimumab.
Infliximab Injection Infliximab Injection The risk or severity of adverse effects can be increased when Infliximab is combined with Ipilimumab.
Duloxetine Duloxetine Duloxetine may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Tinidazole Tinidazole Tinidazole may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Cefditoren Cefditoren Cefdinir may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Natalizumab Injection Natalizumab Injection The risk or severity of adverse effects can be increased when Natalizumab is combined with Ipilimumab.
Cyanocobalamin Injection Cyanocobalamin Injection Hydroxocobalamin may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Eszopiclone Eszopiclone Eszopiclone may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Ganciclovir Ganciclovir Ganciclovir may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Ribavirin Ribavirin Ribavirin may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Valganciclovir Valganciclovir Valganciclovir may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Adefovir Adefovir Adefovir may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Dextroamphetamine Dextroamphetamine Amphetamine may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Ramelteon Ramelteon Ramelteon may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Fentanyl Fentanyl Fentanyl may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Pregabalin Pregabalin Pregabalin may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Ranolazine Ranolazine Ranolazine may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Rasagiline Rasagiline Rasagiline may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Sitagliptin Sitagliptin Sitagliptin may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Varenicline Varenicline Varenicline may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Bevacizumab Injection Bevacizumab Injection The risk or severity of adverse effects can be increased when Bevacizumab is combined with Ipilimumab.
Albuterol Albuterol Salbutamol may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Paliperidone Paliperidone Paliperidone may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Clofarabine Injection Clofarabine Injection Clofarabine may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Lubiprostone Lubiprostone Lubiprostone may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Rituximab Injection Rituximab Injection The risk or severity of adverse effects can be increased when Rituximab is combined with Ipilimumab.
Cetuximab Injection Cetuximab Injection The risk or severity of adverse effects can be increased when Cetuximab is combined with Ipilimumab.
Pemetrexed Injection Pemetrexed Injection Ipilimumab may decrease the excretion rate of Pemetrexed which could result in a higher serum level.
Ranibizumab Injection Ranibizumab Injection The risk or severity of adverse effects can be increased when Ranibizumab is combined with Ipilimumab.
Sorafenib Sorafenib Sorafenib may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Levocetirizine Levocetirizine Ipilimumab may decrease the excretion rate of Levocetirizine which could result in a higher serum level.
Pegaptanib Injection Pegaptanib Injection Pegaptanib may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Panitumumab Injection Panitumumab Injection The risk or severity of adverse effects can be increased when Panitumumab is combined with Ipilimumab.
Azacitidine Injection Azacitidine Injection Azacitidine may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Lenalidomide Lenalidomide Lenalidomide may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Budesonide Budesonide Budesonide may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Desmopressin Desmopressin Desmopressin may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Doripenem Injection Doripenem Injection Ipilimumab may decrease the excretion rate of Doripenem which could result in a higher serum level.
Arsenic Trioxide Injection Arsenic Trioxide Injection Arsenic trioxide may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Desvenlafaxine Desvenlafaxine Ipilimumab may decrease the excretion rate of Desvenlafaxine which could result in a higher serum level.
Cevimeline Cevimeline Cevimeline may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Certolizumab Injection Certolizumab Injection Ipilimumab may decrease the excretion rate of Certolizumab pegol which could result in a higher serum level.
Daptomycin Injection Daptomycin Injection Daptomycin may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Methylnaltrexone Injection Methylnaltrexone Injection Ipilimumab may decrease the excretion rate of Methylnaltrexone which could result in a higher serum level.
Alemtuzumab Injection (Chronic Lymphocytic Leukemia) Alemtuzumab Injection (Chronic Lymphocytic Leukemia) The risk or severity of adverse effects can be increased when Alemtuzumab is combined with Ipilimumab.
Midazolam Midazolam Midazolam may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Dexrazoxane Injection Dexrazoxane Injection Dexrazoxane may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Ibritumomab Injection Ibritumomab Injection The risk or severity of adverse effects can be increased when Ibritumomab tiuxetan is combined with Ipilimumab.
Milnacipran Milnacipran Milnacipran may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Plerixafor Injection Plerixafor Injection Ipilimumab may decrease the excretion rate of Plerixafor which could result in a higher serum level.
Fesoterodine Fesoterodine Ipilimumab may decrease the excretion rate of Fesoterodine which could result in a higher serum level.
Prasugrel Prasugrel Ipilimumab may decrease the excretion rate of Prasugrel which could result in a higher serum level.
Tolvaptan (low blood sodium) Tolvaptan (low blood sodium) Tolvaptan may increase the excretion rate of Ipilimumab which could result in a lower serum level and potentially a reduction in efficacy.
Pralatrexate Injection Pralatrexate Injection Ipilimumab may decrease the excretion rate of Pralatrexate which could result in a higher serum level.
Palonosetron Injection Palonosetron Injection Palonosetron may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Saxagliptin Saxagliptin Ipilimumab may decrease the excretion rate of Saxagliptin which could result in a higher serum level.
Telavancin Injection Telavancin Injection Ipilimumab may decrease the excretion rate of Telavancin which could result in a higher serum level.
Topotecan Topotecan Topotecan may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Ofatumumab Injection (Chronic Lymphocytic Leukemia) Ofatumumab Injection (Chronic Lymphocytic Leukemia) The risk or severity of adverse effects can be increased when Ipilimumab is combined with Ofatumumab.
Golimumab Injection Golimumab Injection The risk or severity of adverse effects can be increased when Ipilimumab is combined with Golimumab.
Denosumab Injection Denosumab Injection The risk or severity of adverse effects can be increased when Ipilimumab is combined with Denosumab.
Tocilizumab Injection Tocilizumab Injection The risk or severity of adverse effects can be increased when Ipilimumab is combined with Tocilizumab.
Dalfampridine Dalfampridine Ipilimumab may decrease the excretion rate of Dalfampridine which could result in a higher serum level.
Ustekinumab Injection Ustekinumab Injection The risk or severity of adverse effects can be increased when Ustekinumab is combined with Ipilimumab.
Ceftaroline Injection Ceftaroline Injection Ceftaroline fosamil may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Acetaminophen Injection Acetaminophen Injection Acetaminophen may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Denileukin Diftitox Injection Denileukin Diftitox Injection Aldesleukin may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Terbutaline Injection Terbutaline Injection Terbutaline may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Belimumab Injection Belimumab Injection The risk or severity of adverse effects can be increased when Ipilimumab is combined with Belimumab.
Roflumilast Roflumilast Roflumilast may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Rivaroxaban Rivaroxaban Ipilimumab may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.
Brentuximab Vedotin Injection Brentuximab Vedotin Injection The risk or severity of adverse effects can be increased when Ipilimumab is combined with Brentuximab vedotin.
Ruxolitinib Ruxolitinib Ipilimumab may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.
Clobazam Clobazam Clobazam may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Vemurafenib Vemurafenib Ipilimumab may increase the hepatotoxic activities of Vemurafenib.
Basiliximab Injection Basiliximab Injection The risk or severity of adverse effects can be increased when Basiliximab is combined with Ipilimumab.
Deferiprone Deferiprone Ipilimumab may decrease the excretion rate of Deferiprone which could result in a higher serum level.
Naloxone Injection Naloxone Injection Naloxone may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Eculizumab Injection Eculizumab Injection The risk or severity of adverse effects can be increased when Eculizumab is combined with Ipilimumab.
Fondaparinux Injection Fondaparinux Injection Fondaparinux may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Pertuzumab Injection Pertuzumab Injection The risk or severity of adverse effects can be increased when Ipilimumab is combined with Pertuzumab.
Enzalutamide Enzalutamide Ipilimumab may decrease the excretion rate of Enzalutamide which could result in a higher serum level.
Mirabegron Mirabegron Ipilimumab may decrease the excretion rate of Mirabegron which could result in a higher serum level.
Teduglutide Injection Teduglutide Injection Ipilimumab may decrease the excretion rate of Teduglutide which could result in a higher serum level.
Alogliptin Alogliptin Ipilimumab may decrease the excretion rate of Alogliptin which could result in a higher serum level.
Pomalidomide Pomalidomide Ipilimumab may decrease the excretion rate of Pomalidomide which could result in a higher serum level.
Ado-trastuzumab Emtansine Injection Ado-trastuzumab Emtansine Injection The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Ipilimumab.
Canagliflozin Canagliflozin Ipilimumab may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy.
Methazolamide Methazolamide Methazolamide may increase the excretion rate of Ipilimumab which could result in a lower serum level and potentially a reduction in efficacy.
Trametinib Trametinib Ipilimumab may decrease the excretion rate of Trametinib which could result in a higher serum level.
Levomilnacipran Levomilnacipran Ipilimumab may decrease the excretion rate of Levomilnacipran which could result in a higher serum level.
Ertapenem Injection Ertapenem Injection Ertapenem may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Vortioxetine Vortioxetine Ipilimumab may decrease the excretion rate of Vortioxetine which could result in a higher serum level.
Ketorolac Injection Ketorolac Injection Ketorolac may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Obinutuzumab Injection Obinutuzumab Injection The risk or severity of adverse effects can be increased when Ipilimumab is combined with Obinutuzumab.
Sofosbuvir Sofosbuvir Ipilimumab may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.
Dapagliflozin Dapagliflozin Dapagliflozin may increase the excretion rate of Ipilimumab which could result in a lower serum level and potentially a reduction in efficacy.
Apremilast Apremilast Apremilast may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Droxidopa Droxidopa Ipilimumab may decrease the excretion rate of Droxidopa which could result in a higher serum level.
Ramucirumab Injection Ramucirumab Injection The risk or severity of adverse effects can be increased when Ramucirumab is combined with Ipilimumab.
Siltuximab Injection Siltuximab Injection The risk or severity of adverse effects can be increased when Ipilimumab is combined with Siltuximab.
Vedolizumab Injection Vedolizumab Injection The risk or severity of adverse effects can be increased when Ipilimumab is combined with Vedolizumab.
Testosterone Injection Testosterone Injection Testosterone may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Dulaglutide Injection Dulaglutide Injection The risk or severity of adverse effects can be increased when Ipilimumab is combined with Dulaglutide.
Pembrolizumab Injection Pembrolizumab Injection The risk or severity of adverse effects can be increased when Ipilimumab is combined with Pembrolizumab.
Edoxaban Edoxaban Ipilimumab may decrease the excretion rate of Edoxaban which could result in a higher serum level.
Nivolumab Injection Nivolumab Injection The risk or severity of adverse effects can be increased when Ipilimumab is combined with Nivolumab.
Blinatumomab Injection Blinatumomab Injection The risk or severity of adverse effects can be increased when Ipilimumab is combined with Blinatumomab.
Methamphetamine Methamphetamine Metamfetamine may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Tasimelteon Tasimelteon Ipilimumab may decrease the excretion rate of Tasimelteon which could result in a higher serum level.
Secukinumab Injection Secukinumab Injection The risk or severity of adverse effects can be increased when Ipilimumab is combined with Secukinumab.
Dinutuximab Injection Dinutuximab Injection The risk or severity of adverse effects can be increased when Ipilimumab is combined with Dinutuximab.
Haloperidol Injection Haloperidol Injection Haloperidol may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Amiloride Amiloride Amiloride may increase the excretion rate of Ipilimumab which could result in a lower serum level and potentially a reduction in efficacy.
Macitentan Macitentan Ipilimumab may decrease the excretion rate of Macitentan which could result in a higher serum level.
Alirocumab Injection Alirocumab Injection The risk or severity of adverse effects can be increased when Ipilimumab is combined with Alirocumab.
Evolocumab Injection Evolocumab Injection The risk or severity of adverse effects can be increased when Ipilimumab is combined with Evolocumab.
Penicillin G Procaine Injection Penicillin G Procaine Injection Ipilimumab may decrease the excretion rate of Procaine benzylpenicillin which could result in a higher serum level.
Mepolizumab Injection Mepolizumab Injection The risk or severity of adverse effects can be increased when Ipilimumab is combined with Mepolizumab.
Elotuzumab Injection Elotuzumab Injection The risk or severity of adverse effects can be increased when Ipilimumab is combined with Elotuzumab.
Daratumumab Injection Daratumumab Injection The risk or severity of adverse effects can be increased when Ipilimumab is combined with Daratumumab.
Ixazomib Ixazomib Ipilimumab may decrease the excretion rate of Ixazomib which could result in a higher serum level.
Necitumumab Injection Necitumumab Injection The risk or severity of adverse effects can be increased when Ipilimumab is combined with Necitumumab.
Lesinurad Lesinurad Ipilimumab may decrease the excretion rate of Lesinurad which could result in a higher serum level.
Amphotericin B Liposomal Injection Amphotericin B Liposomal Injection Amphotericin B may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Reslizumab Injection Reslizumab Injection The risk or severity of adverse effects can be increased when Ipilimumab is combined with Reslizumab.
Ixekizumab Injection Ixekizumab Injection The risk or severity of adverse effects can be increased when Ipilimumab is combined with Ixekizumab.
Brivaracetam Injection Brivaracetam Injection Brivaracetam may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Atezolizumab Injection Atezolizumab Injection The risk or severity of adverse effects can be increased when Ipilimumab is combined with Atezolizumab.
Furosemide Injection Furosemide Injection Furosemide may increase the excretion rate of Ipilimumab which could result in a lower serum level and potentially a reduction in efficacy.
Olaratumab Injection Olaratumab Injection The risk or severity of adverse effects can be increased when Olaratumab is combined with Ipilimumab.
Bezlotoxumab Injection Bezlotoxumab Injection The risk or severity of adverse effects can be increased when Ipilimumab is combined with Bezlotoxumab.
Lixisenatide Injection Lixisenatide Injection Ipilimumab may decrease the excretion rate of Lixisenatide which could result in a higher serum level.
Avelumab Injection Avelumab Injection The risk or severity of adverse effects can be increased when Ipilimumab is combined with Avelumab.
Brodalumab Injection Brodalumab Injection The risk or severity of adverse effects can be increased when Ipilimumab is combined with Brodalumab.
Doxepin (Insomnia) Doxepin (Insomnia) Doxepin may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Dupilumab Injection Dupilumab Injection The risk or severity of adverse effects can be increased when Ipilimumab is combined with Dupilumab.
Deutetrabenazine Deutetrabenazine Ipilimumab may decrease the excretion rate of Deutetrabenazine which could result in a higher serum level.
Valbenazine Valbenazine Ipilimumab may decrease the excretion rate of Valbenazine which could result in a higher serum level.
Ocrelizumab Injection Ocrelizumab Injection The risk or severity of adverse effects can be increased when Ipilimumab is combined with Ocrelizumab.
Durvalumab Injection Durvalumab Injection The risk or severity of adverse effects can be increased when Ipilimumab is combined with Durvalumab.
Naldemedine Naldemedine Ipilimumab may decrease the excretion rate of Naldemedine which could result in a higher serum level.
Sarilumab Injection Sarilumab Injection The risk or severity of adverse effects can be increased when Ipilimumab is combined with Sarilumab.
Guselkumab Injection Guselkumab Injection The risk or severity of adverse effects can be increased when Ipilimumab is combined with Guselkumab.
Inotuzumab Ozogamicin Injection Inotuzumab Ozogamicin Injection The risk or severity of adverse effects can be increased when Inotuzumab ozogamicin is combined with Ipilimumab.
Benznidazole Benznidazole Ipilimumab may decrease the excretion rate of Benznidazole which could result in a higher serum level.
Delafloxacin Delafloxacin Ipilimumab may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Benralizumab Injection Benralizumab Injection The risk or severity of adverse effects can be increased when Ipilimumab is combined with Benralizumab.
Gemtuzumab Ozogamicin Injection Gemtuzumab Ozogamicin Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Ipilimumab.
Ertugliflozin Ertugliflozin Ertugliflozin may increase the excretion rate of Ipilimumab which could result in a lower serum level and potentially a reduction in efficacy.
Apalutamide Apalutamide Ipilimumab may decrease the excretion rate of Apalutamide which could result in a higher serum level.
Ibalizumab-uiyk Injection Ibalizumab-uiyk Injection The risk or severity of adverse effects can be increased when Ipilimumab is combined with Ibalizumab.
Tildrakizumab-asmn injection Tildrakizumab-asmn injection The risk or severity of adverse effects can be increased when Ipilimumab is combined with Tildrakizumab.
Erenumab-aooe Injection Erenumab-aooe Injection The risk or severity of adverse effects can be increased when Ipilimumab is combined with Erenumab.
Baricitinib Baricitinib Ipilimumab may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Burosumab-twza Injection Burosumab-twza Injection The risk or severity of adverse effects can be increased when Ipilimumab is combined with Burosumab.
Lofexidine Lofexidine Lofexidine may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Plazomicin Injection Plazomicin Injection Ipilimumab may decrease the excretion rate of Plazomicin which could result in a higher serum level.
Cemiplimab-rwlc Injection Cemiplimab-rwlc Injection The risk or severity of adverse effects can be increased when Ipilimumab is combined with Cemiplimab.
Galcanezumab-gnlm Injection Galcanezumab-gnlm Injection The risk or severity of adverse effects can be increased when Ipilimumab is combined with Galcanezumab.
Mogamulizumab-kpkc Injection Mogamulizumab-kpkc Injection The risk or severity of adverse effects can be increased when Ipilimumab is combined with Mogamulizumab.
Stiripentol Stiripentol Ipilimumab may decrease the excretion rate of Stiripentol which could result in a higher serum level.
Methoxy Polyethylene Glycol-Epoetin Beta Injection Methoxy Polyethylene Glycol-Epoetin Beta Injection The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Ipilimumab.
Prucalopride Prucalopride Ipilimumab may decrease the excretion rate of Prucalopride which could result in a higher serum level.
Ravulizumab-cwvz Injection Ravulizumab-cwvz Injection The risk or severity of adverse effects can be increased when Ipilimumab is combined with Ravulizumab.
Emapalumab-lzsg Injection Emapalumab-lzsg Injection The risk or severity of adverse effects can be increased when Ipilimumab is combined with Emapalumab.
Romosozumab-aqqg Injection Romosozumab-aqqg Injection The risk or severity of adverse effects can be increased when Ipilimumab is combined with Romosozumab.
Acyclovir Ophthalmic Acyclovir Ophthalmic Acyclovir may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Caplacizumab-yhdp Injection Caplacizumab-yhdp Injection The risk or severity of adverse effects can be increased when Caplacizumab is combined with Ipilimumab.
Risankizumab-rzaa Injection Risankizumab-rzaa Injection The risk or severity of adverse effects can be increased when Ipilimumab is combined with Risankizumab.
Polatuzumab vedotin-piiq Injection Polatuzumab vedotin-piiq Injection The risk or severity of adverse effects can be increased when Ipilimumab is combined with Polatuzumab vedotin.
Solriamfetol Solriamfetol Ipilimumab may decrease the excretion rate of Solriamfetol which could result in a higher serum level.
Pitolisant Pitolisant Ipilimumab may decrease the excretion rate of Pitolisant which could result in a higher serum level.
Brolucizumab-dbll Injection Brolucizumab-dbll Injection The risk or severity of adverse effects can be increased when Ipilimumab is combined with Brolucizumab.
Fam-trastuzumab deruxtecan-nxki Injection Fam-trastuzumab deruxtecan-nxki Injection The risk or severity of adverse effects can be increased when Ipilimumab is combined with Trastuzumab deruxtecan.
Isatuximab-irfc Injection Isatuximab-irfc Injection The risk or severity of adverse effects can be increased when Ipilimumab is combined with Isatuximab.
Teprotumumab-trbw Injection Teprotumumab-trbw Injection The risk or severity of adverse effects can be increased when Ipilimumab is combined with Teprotumumab.
Sacituzumab govitecan-hziy Injection Sacituzumab govitecan-hziy Injection The risk or severity of adverse effects can be increased when Ipilimumab is combined with Sacituzumab govitecan.
Luspatercept-aamt Injection Luspatercept-aamt Injection The risk or severity of adverse effects can be increased when Ipilimumab is combined with Luspatercept.
Belantamab Mafodotin-blmf Injection Belantamab Mafodotin-blmf Injection The risk or severity of adverse effects can be increased when Ipilimumab is combined with Belantamab mafodotin.
Tafasitamab-cxix Injection Tafasitamab-cxix Injection The risk or severity of adverse effects can be increased when Ipilimumab is combined with Tafasitamab.
Margetuximab-cmkb Injection Margetuximab-cmkb Injection The risk or severity of adverse effects can be increased when Ipilimumab is combined with Margetuximab.
Progestin-Only (drospirenone) Oral Contraceptives Progestin-Only (drospirenone) Oral Contraceptives Drospirenone may increase the excretion rate of Ipilimumab which could result in a lower serum level and potentially a reduction in efficacy.
Evinacumab-dgnb Injection Evinacumab-dgnb Injection The risk or severity of adverse effects can be increased when Ipilimumab is combined with Evinacumab.
Viloxazine Viloxazine Ipilimumab may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Aducanumab-avwa Injection Aducanumab-avwa Injection The risk or severity of adverse effects can be increased when Ipilimumab is combined with Aducanumab.
Anifrolumab-fnia Injection Anifrolumab-fnia Injection The risk or severity of adverse effects can be increased when Ipilimumab is combined with Anifrolumab.
Tobramycin Injection Tobramycin Injection Tobramycin may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Fenoprofen Fenoprofen Fenoprofen may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Indomethacin Indomethacin Indomethacin may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Mefenamic Acid Mefenamic Acid Mefenamic acid may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Naproxen Naproxen Naproxen may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Tolmetin Tolmetin Tolmetin may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Sulindac Sulindac Sulindac may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Isotretinoin Isotretinoin Isotretinoin may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Sucralfate Sucralfate Sucralfate may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Floxuridine Floxuridine Floxuridine may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Metaxalone Metaxalone Metaxalone may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Methotrexate Injection Methotrexate Injection Methotrexate may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Chlorpromazine Chlorpromazine Chlorpromazine may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Diazepam Diazepam Diazepam may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Oxazepam Oxazepam Oxazepam may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Flurazepam Flurazepam Flurazepam may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Clorazepate Clorazepate Clorazepic acid may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Lorazepam Lorazepam Lorazepam may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Carmustine Carmustine Carmustine may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Amantadine Amantadine Amantadine may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Codeine Codeine Codeine may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Phenelzine Phenelzine Phenelzine may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Tetracycline Tetracycline Tetracycline may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Bleomycin Bleomycin Bleomycin may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Sulfadiazine Sulfadiazine Sulfadiazine may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Methadone Methadone Methadone may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Benztropine Benztropine Benzatropine may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Maprotiline Maprotiline Maprotiline may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Ibuprofen Ibuprofen Ibuprofen may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Azathioprine Azathioprine Azathioprine may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Methylphenidate Methylphenidate Methylphenidate may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Sulfasalazine Sulfasalazine Sulfasalazine may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Phenazopyridine Phenazopyridine Phenazopyridine may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Carbamazepine Carbamazepine Ipilimumab may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Methyldopa Methyldopa Methyldopa may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Hydralazine Hydralazine Hydralazine may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Cimetidine Cimetidine Cimetidine may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Gentamicin Injection Gentamicin Injection Gentamicin may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Warfarin Warfarin Ipilimumab may decrease the excretion rate of Warfarin which could result in a higher serum level.
Clonazepam Clonazepam Clonazepam may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Promethazine Promethazine Promethazine may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Meclofenamate Meclofenamate Meclofenamic acid may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Nitrofurantoin Nitrofurantoin Nitrofurantoin may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Digoxin Digoxin Ipilimumab may decrease the excretion rate of Digoxin which could result in a higher serum level.
Chloroquine Chloroquine Chloroquine may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Triamterene Triamterene Triamterene may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Chlorothiazide Chlorothiazide Chlorothiazide may increase the excretion rate of Ipilimumab which could result in a lower serum level and potentially a reduction in efficacy.
Chlorthalidone Chlorthalidone Chlorthalidone may increase the excretion rate of Ipilimumab which could result in a lower serum level and potentially a reduction in efficacy.
Metolazone Metolazone Metolazone may increase the excretion rate of Ipilimumab which could result in a lower serum level and potentially a reduction in efficacy.
Isosorbide Isosorbide Isosorbide may increase the excretion rate of Ipilimumab which could result in a lower serum level and potentially a reduction in efficacy.
Secobarbital Secobarbital Secobarbital may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Desipramine Desipramine Desipramine may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Amitriptyline Amitriptyline Amitriptyline may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Imipramine Imipramine Imipramine may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Probenecid Probenecid Probenecid may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Quinidine Quinidine Ipilimumab may decrease the excretion rate of Quinidine which could result in a higher serum level.
Procainamide Procainamide Ipilimumab may decrease the excretion rate of Procainamide which could result in a higher serum level.
Isoniazid Isoniazid Isoniazid may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Pyrazinamide Pyrazinamide Pyrazinamide may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Disopyramide Disopyramide Disopyramide may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Butabarbital Butabarbital Butabarbital may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Liothyronine Liothyronine Liothyronine may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Methimazole Methimazole Methimazole may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Chlorpropamide Chlorpropamide Chlorpropamide may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Tolbutamide Tolbutamide Tolbutamide may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Tolazamide Tolazamide Tolazamide may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Baclofen Baclofen Baclofen may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Ethambutol Ethambutol Ethambutol may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Methyclothiazide Methyclothiazide Methyclothiazide may increase the excretion rate of Ipilimumab which could result in a lower serum level and potentially a reduction in efficacy.
Hydrochlorothiazide Hydrochlorothiazide Hydrochlorothiazide may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Chlorzoxazone Chlorzoxazone Chlorzoxazone may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Pyridoxine Pyridoxine Pyridoxine may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Folic Acid Folic Acid Folic acid may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Propranolol (Cardiovascular) Propranolol (Cardiovascular) Propranolol may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Spironolactone Spironolactone Spironolactone may increase the excretion rate of Ipilimumab which could result in a lower serum level and potentially a reduction in efficacy.
Amphotericin B Injection Amphotericin B Injection Amphotericin B may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Phytonadione Phytonadione Phylloquinone may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Amikacin Injection Amikacin Injection Amikacin may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Nadolol Nadolol Nadolol may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Allopurinol Allopurinol Allopurinol may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Flavoxate Flavoxate Flavoxate may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Colchicine Colchicine Colchicine may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Cefaclor Cefaclor Cefaclor may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Cefadroxil Cefadroxil Cefadroxil may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Cefazolin Injection Cefazolin Injection Cefazolin may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Cephalexin Cephalexin Cephalexin may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Cefoxitin Injection Cefoxitin Injection Cefoxitin may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Dacarbazine Dacarbazine Dacarbazine may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Acetazolamide Acetazolamide Acetazolamide may increase the excretion rate of Ipilimumab which could result in a lower serum level and potentially a reduction in efficacy.
Cefotaxime Injection Cefotaxime Injection Cefotaxime may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Calcitonin Salmon Injection Calcitonin Salmon Injection Salmon calcitonin may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Pyrantel Pyrantel Ipilimumab may decrease the excretion rate of Pyrantel which could result in a higher serum level.
Ethacrynic Acid Ethacrynic Acid Etacrynic acid may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Colistimethate Injection Colistimethate Injection Colistimethate may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Metoprolol Metoprolol Metoprolol may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Aspirin Aspirin Acetylsalicylic acid may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Salsalate Salsalate Salsalate may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Alprazolam Alprazolam Alprazolam may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Temazepam Temazepam Temazepam may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Triazolam Triazolam Triazolam may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Dicyclomine Dicyclomine Dicyclomine may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Propantheline Propantheline Propantheline may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Trimethoprim Trimethoprim Trimethoprim may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Nifedipine Nifedipine Nifedipine may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Timolol Timolol Timolol may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Verapamil Verapamil Verapamil may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Pindolol Pindolol Pindolol may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Cisplatin Injection Cisplatin Injection Ipilimumab may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Diflunisal Diflunisal Diflunisal may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Piroxicam Piroxicam Piroxicam may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Bumetanide Bumetanide Bumetanide may increase the excretion rate of Ipilimumab which could result in a lower serum level and potentially a reduction in efficacy.
Glipizide Glipizide Glipizide may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Indapamide Indapamide Indapamide may increase the excretion rate of Ipilimumab which could result in a lower serum level and potentially a reduction in efficacy.
Amoxicillin Amoxicillin Amoxicillin may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Oxacillin Injection Oxacillin Injection Oxacillin may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Pentoxifylline Pentoxifylline Pentoxifylline may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Pentamidine Injection Pentamidine Injection Pentamidine may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Ceftriaxone Injection Ceftriaxone Injection Ceftriaxone may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Labetalol Labetalol Labetalol may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Auranofin Auranofin Auranofin may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Leuprolide Injection Leuprolide Injection Leuprolide may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Gemfibrozil Gemfibrozil Gemfibrozil may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Dipivefrin Ophthalmic Dipivefrin Ophthalmic Adefovir dipivoxil may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Ceftazidime Injection Ceftazidime Injection Ceftazidime may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Ketoprofen Ketoprofen Ketoprofen may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Cefotetan Injection Cefotetan Injection Cefotetan may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Flurbiprofen Flurbiprofen Flurbiprofen may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Aztreonam Injection Aztreonam Injection Aztreonam may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Buspirone Buspirone Buspirone may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Ciprofloxacin Ciprofloxacin Ciprofloxacin may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Mesalamine Mesalamine Mesalazine may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Diclofenac Diclofenac Diclofenac may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Clozapine Clozapine Clozapine may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Estazolam Estazolam Estazolam may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Didanosine Didanosine Didanosine may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Pentostatin Injection Pentostatin Injection Pentostatin may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Etodolac Etodolac Etodolac may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Fosinopril Fosinopril Fosinopril may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Nabumetone Nabumetone Nabumetone may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Epoetin Alfa, Injection Epoetin Alfa, Injection The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Ipilimumab.
Lisinopril Lisinopril Lisinopril may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Oxaprozin Oxaprozin Oxaprozin may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Bisoprolol Bisoprolol Bisoprolol may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Isradipine Isradipine Isradipine may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Venlafaxine Venlafaxine Venlafaxine may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Fluvoxamine Fluvoxamine Fluvoxamine may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Nefazodone Nefazodone Nefazodone may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Lamotrigine Lamotrigine Lamotrigine may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Valacyclovir Valacyclovir Valaciclovir may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Tramadol Tramadol Tramadol may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Carboplatin Injection Carboplatin Injection Carboplatin may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Ifosfamide Injection Ifosfamide Injection Ifosfamide may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Bupropion Bupropion Bupropion may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Ticlopidine Ticlopidine Ticlopidine may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Metformin Metformin Metformin may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Nisoldipine Nisoldipine Nisoldipine may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Lamivudine Lamivudine Lamivudine may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Acarbose Acarbose Acarbose may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Gemcitabine Injection Gemcitabine Injection Gemcitabine may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Cidofovir Injection Cidofovir Injection Cidofovir may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Meropenem Injection Meropenem Injection Meropenem may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Clomipramine Clomipramine Clomipramine may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Fosfomycin Fosfomycin Fosfomycin may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Topiramate Topiramate Topiramate may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Pramipexole Pramipexole Pramipexole may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Nilutamide Nilutamide Nilutamide may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Flutamide Flutamide Flutamide may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Tamsulosin Tamsulosin Tamsulosin may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Quetiapine Quetiapine Quetiapine may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Cefepime Injection Cefepime Injection Cefepime may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Cefprozil Cefprozil Cefprozil may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Cefpodoxime Cefpodoxime Cefpodoxime may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Cetirizine Cetirizine Cetirizine may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Palivizumab Injection Palivizumab Injection The risk or severity of adverse effects can be increased when Palivizumab is combined with Ipilimumab.
Tolcapone Tolcapone Tolcapone may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Capecitabine Capecitabine Capecitabine may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Abacavir Abacavir Abacavir may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Trastuzumab Injection Trastuzumab Injection The risk or severity of adverse effects can be increased when Trastuzumab is combined with Ipilimumab.
Celecoxib Celecoxib Celecoxib may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Rosiglitazone Rosiglitazone Rosiglitazone may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Tolterodine Tolterodine Tolterodine may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Oseltamivir Oseltamivir Oseltamivir may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Balsalazide Balsalazide Balsalazide may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Nateglinide Nateglinide Nateglinide may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Rabeprazole Rabeprazole Rabeprazole may decrease the excretion rate of Ipilimumab which could result in a higher serum level.

Content provided by: AHFS® Patient Medication Information™. © Copyright, 2021. The American Society of Health-System Pharmacists